Skip to page content
Veteran Mission Control emblemVeteran Mission ControlMission Control for the Benefits You Earned
Army
Marine Corps
Navy
Air Force
Space Force
Coast Guard
Veteran BuiltAir Force • ArmyPrivacy First · Local-first

VASRD reference

VA Diagnostic Codes

Search source-verified VA diagnostic-code identities, body systems, historical status, and regulatory provenance.
Official SourcesLocal OnlyVeteran Built

This reference uses VA rating codes. For a code from a medical record, check ICD-10-CM and the service date. A clinical code alone does not establish a VA rating or a matching VA diagnostic code.

DC 7818ACTIVESource verified

Malignant skin neoplasms (other than malignant melanoma)

Skin · 38 CFR § 4.118

Diagnostic Code 7818 is the VASRD entry for Malignant skin neoplasms (other than malignant melanoma). VA applies the controlling criteria, shared formulas, and special instructions shown in 38 CFR Part 4. VMC presents this material for education and reference; it does not determine a Veteran's diagnosis, service connection, or evaluation.

Recorded index labels

These labels are already stored for this diagnostic code. They are not a new condition, rating, or medical relationship.

Appendix B

  • Malignant skin neoplasms.

Appendix C

  • Skin

Print the source-verified reference on this page, or choose Save as PDF in your browser’s print dialog.

Rate-under relationships

Rate under / reference DC 7800

Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC's 7801, 7802, 7803, 7804, or 7805), or impairment of function

Rate under / reference DC 7801

Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC's 7801, 7802, 7803, 7804, or 7805), or impairment of function

Special rating instructions

  • Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC's 7801, 7802, 7803, 7804, or 7805), or impairment of function Note: If a skin malignancy requires therapy that is comparable to that used for systemic malignancies, i.e. , systemic chemotherapy, X-ray therapy more extensive than to the skin, or surgery more extensive than wide local excision, a 100-percent evaluation will be assigned from the date of onset of treatment, and will continue, with a mandatory VA examination six months following the completion of such antineoplastic treatment, and any change in evaluation based upon that or any subsequent examination will be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, evaluation will then be made on residuals. If treatment is confined to the skin, the provisions for a 100-percent evaluation do not apply.

Regulatory notes

  • Note: If a skin malignancy requires therapy that is comparable to that used for systemic malignancies, i.e. , systemic chemotherapy, X-ray therapy more extensive than to the skin, or surgery more extensive than wide local excision, a 100-percent evaluation will be assigned from the date of onset of treatment, and will continue, with a mandatory VA examination six months following the completion of such antineoplastic treatment, and any change in evaluation based upon that or any subsequent examination will be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, evaluation will then be made on residuals. If treatment is confined to the skin, the provisions for a 100-percent evaluation do not apply.

Body system and anatomy metadata

Body system: Skin

Anatomy / region tags: multi region

These tags support discovery and body-map compatibility. They do not establish Veteran-specific laterality or entitlement.

Official VA DBQ references

DBQ catalog: va-dbq-2026.09.16 · Retrieved 2026-09-16. Official VA inventory ↗

  • Scars ↗ Related resourceCatalog category: Dermatological

    Related by body system only. No reviewed condition-specific form match or requirement has been established.

  • Skin Diseases ↗ Related resourceCatalog category: Dermatological

    Related by body system only. No reviewed condition-specific form match or requirement has been established.

VA maintains some examination forms that are not available for public use. VMC does not infer a one-code-to-one-DBQ relationship.

Evidence information

When reviewing the criteria, useful evidence categories can include diagnosis and treatment records, objective testing identified by the schedule, documented frequency/duration/severity when the criteria use those concepts, and functional effects described in medical or lay evidence. The relevant evidence depends on the actual claim and medical facts.

VMC does not diagnose conditions, guarantee a percentage, or advise anyone to exaggerate symptoms.

Related diagnostic codes

Legal basis and source identification

38 CFR § 4.118 · Source current through 2026-08-06 · Verified 2026-08-10

Registry content release: vasrd-registry-2026.08.1